{"id":"NCT00876395","sponsor":"Novartis Pharmaceuticals","briefTitle":"Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer","officialTitle":"A Randomized Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Everolimus in Combination With Trastuzumab and Paclitaxel, as First Line Therapy in Women With HER2 Positive Locally Advanced or Metastatic Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09-10","primaryCompletion":"2014-05-30","completion":"2017-10-23","firstPosted":"2009-04-06","resultsPosted":"2018-12-19","lastUpdate":"2018-12-19"},"enrollment":719,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Everolimus","otherNames":["RAD001"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Trastuzumab","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]}],"arms":[{"label":"Everolimus + Paclitaxel + Trastuzumab","type":"EXPERIMENTAL"},{"label":"Placebo + Paclitaxel + Trastuzumab","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this Phase III study was to confirm the value of adding everolimus to weekly paclitaxel and trastuzumab as treatment of HER2-overexpressing metastatic breast cancer.","primaryOutcome":{"measure":"Progression-free Survival (PFS) Per Investigators' Assessment Based on Local Radiology Review - Full Population","timeFrame":"date of randomization to the date of first documented tumor progression or death from any cause, whichever occurs first, reported between day of first patient randomized up to about 56 months","effectByArm":[{"arm":"Everolimus + Paclitaxel + Trastuzumab","deltaMin":14.95,"sd":null},{"arm":"Placebo + Paclitaxel + Trastuzumab","deltaMin":14.49,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1166"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":11},"locations":{"siteCount":140,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","China","Colombia","Egypt","France","Germany","Greece","Hong Kong","Ireland","Italy","Japan","Lebanon","Mexico","Peru","Puerto Rico","Russia","South Africa","South Korea","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom","Venezuela"]},"refs":{"pmids":["28399902","26861602","26092818"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":173,"n":472},"commonTop":["Stomatitis","Diarrhoea","Alopecia","Cough","Fatigue"]}}